- Home
- OBT vs VNDA Comparison
OBT vs VNDA Comparison
Compare OBT & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OBT | VNDA |
|---|---|---|
| Founded | 1892 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.0M | 398.9M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | OBT | VNDA |
|---|---|---|
| Price | $28.59 | $7.05 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $31.00 | $14.00 |
| AVG Volume (30 Days) | 34.0K | ★ 1.3M |
| Earning Date | 02-04-2026 | 02-12-2026 |
| Dividend Yield | ★ 2.51% | N/A |
| EPS Growth | ★ 18.38 | N/A |
| EPS | ★ 3.03 | N/A |
| Revenue | $115,418,000.00 | ★ $212,074,000.00 |
| Revenue This Year | $19.86 | $12.01 |
| Revenue Next Year | $7.20 | $21.57 |
| P/E Ratio | $9.49 | ★ N/A |
| Revenue Growth | ★ 17.75 | 11.12 |
| 52 Week Low | $20.97 | $3.81 |
| 52 Week High | $30.25 | $7.20 |
Technical Indicators
Market Signals| Indicator | OBT | VNDA |
|---|---|---|
| Relative Strength Index (RSI) | 59.04 | 67.61 |
| Support Level | $28.19 | $6.75 |
| Resistance Level | $30.23 | $7.20 |
| Average True Range (ATR) | 0.77 | 0.47 |
| MACD | -0.09 | 0.04 |
| Stochastic Oscillator | 52.08 | 87.77 |
Price Performance
Historical ComparisonAbout OBT Orange County Bancorp Inc.
Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.